Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis (Q87775354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

title

Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Romina Lomonaco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Beverly Orsak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Carolina Ortiz-Lopez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Amy Webb

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Fermin Tio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Joan Hecht

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Kenneth Cusi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

25 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

2178-2187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

Effect of liver fat on insulin clearance

16 March 2020

cites work

1 reference

7 January 2021

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

7 January 2021

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

1 reference

7 January 2021

Insulin resistance in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes

1 reference

7 January 2021

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

1 reference

7 January 2021

Beta-cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model.

1 reference

7 January 2021

Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity

1 reference

7 January 2021

Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.

1 reference

7 January 2021

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

1 reference

7 January 2021

Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.

1 reference

7 January 2021

Diagnosis and classification of diabetes mellitus

1 reference

7 January 2021

Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients

1 reference

7 January 2021

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

7 January 2021

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

1 reference

7 January 2021

Endpoints and clinical trial design for nonalcoholic steatohepatitis

1 reference

7 January 2021

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

1 reference

7 January 2021

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

1 reference

7 January 2021

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

1 reference

7 January 2021

Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study

1 reference

7 January 2021

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

1 reference

7 January 2021

Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?

1 reference

7 January 2021

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

1 reference

7 January 2021

Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

7 January 2021

Kupffer cell activation is a causal factor for hepatic insulin resistance

1 reference

7 January 2021

The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777953%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference